Asmaa Jasim Thanon (1), Aseel Mahmood Khadim (2), Rawa Ismail Ibrahim (3)
Background: UTIs are a major health issue affecting pregnant women and may result in negative maternal and fetal outcomes. This paper set out to determine the prevalence, risk factors, clinical presentation, microbiological profile, therapeutic intervention, and outcome of UTIs in a group of pregnant women in various hospitals in Iraq.
Where involved 120 pregnant individuals. The information was obtained through structured questionnaires and clinical assessments, such as the urinalysis and urine culture to detect the etiologic agents. Statistical tests used were descriptive and inferential association analysis between demographic and clinical variables.
Findings: The researchers have found that 37.5 per cent of the participants experienced symptomatic UTIs and 25 per cent of asymptomatic bacteriuria. The significant risk factors were a history of UTIs (Odds Ratio = 3.5) and diabetes mellitus (Odds Ratio = 2.2). The most commonly isolated pathogen was Escherichia coli (50 percent), and then came Klebsiella spp. (16.7 percent). Nitrofurantoin became the most widely prescribed antibiotic, and an overall treatment success rate of 88.9% where concluded. The management of UTI requires early screening and intervention.
1. Pedro RN, Das K, Buchholz N. Urolithiasis in pregnancy. Int J Surg. 2016;36:688–92. doi: 10.1016/j.ijsu.2016.10.046. [DOI] [PubMed] [Google Scholar]
2. Grosjean J, Cannie M, de Meyer J-M. Physiological hydronephrosis in pregnancy: Occurrence and possible causes. An MRI study. In: Grosjean J, editor. Francaise Urol. Vol. 27. 2017. pp. 603–8. [DOI] [PubMed] [Google Scholar]
3. Rasmussen PE, Nielsen FR. Hydronephrosis during pregnancy: A literature survey. Eur J Obstet Gynecol Reprod Biol. 1988;27:249–59. doi: 10.1016/0028-2243(88)90130-X. [DOI] [PubMed] [Google Scholar]
4. Richard, MD. Physiological bladder changes during pregnancy and the puerperium. J Urol. 1939;41:691–5. doi: 10.1016/S0022-5347(17)71705-3. [DOI] [Google Scholar]
5. Anonymous. Hinman’s atlas of urosurgical anatomy, 2d ed. (online access included) Ref Res Book News. 2012;27 [Google Scholar]
6. Swift S, Ostergard D. Effects of progesterone on the urinary tract. Pelvic Floor Dysfunct. 1993;4:232–6. doi: 10.1007/BF00372346. [DOI] [Google Scholar]
7. Shah MS, Tozzo PJ. Right ovarian vein syndrome. Urology. 1974;3:488–90. doi: 10.1016/S0090-4295(74)80171-8. [DOI] [PubMed] [Google Scholar]
8. Chou CY, Ting IW, Lin TH, Lee CN. Pregnancy in patients on chronic dialysis: a single-center experience and combined analysis of reported results. Eur J Obstet Gynecol Reprod Biol. 2008;136:165–170. doi: 10.1016/j.ejogrb.2007.01.017. [DOI] [PubMed] [Google Scholar]
9. Krcmery S, Hromec J, Demesova D. Treatment of lower urinary tract infection in pregnancy. Int J Antimicrob Agents. 2001;17:279–282. doi: 10.1016/s0924-8579(00)00351-4. [DOI] [PubMed] [Google Scholar]
10. Cunningham FG, Lucas MJ. Urinary tract infections complicating pregnancy. Baillieres Clin Obstet Gynaecol. 1994;8:353–373. doi: 10.1016/s0950-3552(05)80325-6. [DOI] [PubMed] [Google Scholar]
11. Hooton TM, Stamm WE. Diagnosis and treatment of an uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997;11:551–581. doi: 10.1016/s0891-5520(05)70373-1. [DOI] [PubMed] [Google Scholar]
12. Vazquez JC, Villar J. Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Database Syst Rev. 2003;4:CD002256. doi: 10.1002/14651858.CD002256. [DOI] [PubMed] [Google Scholar]
13. Nicolle LE. Urinary tract infection: traditional pharmacologic therapies. Dis Mon. 2003;49:111–128. doi: 10.1067/mda.2003.11. [DOI] [PubMed] [Google Scholar]
14. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med. 2001;135:41–50. doi: 10.7326/0003-4819-135-1-200107030-00012. [DOI] [PubMed] [Google Scholar]
15. Arslan H, Azap OK, Ergönül O, Timur Kaynak F. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother. 2005;56:914–918. doi: 10.1093/jac/dki344. [DOI] [PubMed] [Google Scholar]
16. Bouza E, San Juan R, Muñoz P, Voss A, Kluytmans J. A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology, and antimicrobial susceptibility (ESGNI-003 study) Clin Microbiol Infect. 2001;7:523–531. doi: 10.1046/j.1198-743x.2001.00326.x. [DOI] [PubMed] [Google Scholar]
17. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113((suppl 1A)):5S–13S. doi: 10.1016/s0002-9343(02)01054-9. [DOI] [PubMed] [Google Scholar]
18. Schieve LA, Handler A, Hershow R, Persky V, Davis F. Urinary tract infection during pregnancy: its association with maternal morbidity and perinatal outcome. Am J Public Health. 1994;84:405–410. doi: 10.2105/ajph 84.3.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
19. Mazor-Dray E, Levy A, Schlaeffer F, Sheiner E. Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome? J Matern Fetal Neonatal Med. 2009;22:124–128. doi: 10.1080/14767050802488246. [DOI] [PubMed] [Google Scholar]
20. Hsu C, Witter F. Urogenital infection in preeclampsia. Int J Gynecol Obstet. 1995;49:271–275. doi: 10.1016/0020-7292(95)02373-k. [DOI] [PubMed] [Google Scholar]